Sorry! JavaScript is disabled in your browser. To get the best user experience on our website you should enable it.

Liquid Biopsy Market Trends, Outlook and Demand by top Leaders

1 month ago

ID: #467928

Business Description

Market Overview
The Global Liquid Biopsy Market is expected to register 28.0% CAGR and is projected to reach USD 17,372.28 million by 2022.
Market Dynamics
Liquid biopsies eliminate the pain associated with the operation by avoiding the painful extraction of the tissue sample. Blood and urine, for example, make up the majority of liquid samples utilized in the technique and are relatively painless to collect. However, other procedures, like as spinal fluid, are uncomfortable. As a result, liquid biopsy minimizes patient anxiety about discomfort. It also provides a safe and effective way for patients who cannot have a tissue biopsy due to the hazards involved, such as lung cancer patients with tumors that are dangerously close to the heart. The commercial implementation of the method was also fueled by advancements in detection technologies such as digital PCR, enhanced cell capture technology, and multi-panel detection. The government's and worldwide health organizations' activities, as well as technology improvements aimed at increasing market revenues, are some of the drivers propelling the global liquid biopsy market forward.
Segmental Analysis
Biomarker types, applications, samples, and end users have all been classified in the worldwide liquid biopsy market.
The global market is divided into circulating tumor cells (CTCS), circulating tumor DNA (CTDNA), extracellular vesicles (EVS), and others based on biomarker types.
The global market has been categorized into cancer, reproductive health, and others based on application.
The global market is divided into four categories based on sample: blood sample, urine sample, forensic sample, and other sample.
The global market is divided into hospitals and laboratories, academic and research centers, and other end users based on end user.
Regional Overview
The global liquid biopsy market in healthcare is divided into four regions: North America, Europe, Asia-Pacific, and the Middle East and Africa.
In 2016, North America held the greatest market share of 37.95 percent, while Asia-Pacific was the fastest-growing region. The technology of liquid biopsy was developed in the United States and numerous European countries, as evidenced by their respective market share supremacy.
With a CAGR of 28.5 percent, the European market is expected to develop the fastest. There are a number of major private organizations working on liquid biopsy test development, and it is only a matter of time until these techniques become commonplace in oncologists' and pathologists' diagnostic tools.
The fastest-growing market is Asia-Pacific, which is predicted to increase at a CAGR of 29.7% over the forecasted period. This is due to an increase in disposable income, government attempts to update healthcare infrastructure, and an increase in healthcare spending. Furthermore, strategic approvals and partnerships between major market players to promote liquid biopsy technology in this region are projected to support market growth.
Browse Complete Report @ https://www.marketresearchfuture.com/reports/liquid-biopsy-market-710
Competitive Dynamics
The major players in the global liquid biopsy market are Guardant Health, Inc. (US), Trovagene, Inc. (California), RainDance Technologies, Inc. (US), Agena Bioscience Inc. (California), Admera Health (US), Biocept, Inc. KGaA (US), Circulogene Theranostics (Alabama), Inivata Ltd (UK), SAGA Diagnostics AB (Sweden), and Exosome Diagnostics (Massachusetts).

You can Read More Reports Here!!
https://www.marketresearchfuture.com/categories/healthcare-market-report
https://www.marketresearchfuture.com/categories/pharmaceutical-market-report
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Follow Us: LinkedIn | Twitter
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/


No Review.

Please login / register to add your review.